We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Says Genta May Resume Clinical Trial of Tesetaxel
FDA Says Genta May Resume Clinical Trial of Tesetaxel
June 27, 2008
Genta has received notification from the FDA that it may resume clinical trials with its oncology drug tesetaxel.